Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Pivot Pharmaceuticals Inc. | neurokineform8kchangeofaudit.htm |
![[exhibit161001.jpg]](exhibit161001.jpg)
Exhibit 16.1
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
U.S.A.
Dear Ladies and Gentlemen:
Re: Neurokine Pharmaceuticals Inc. (the “Company”)
This letter confirms that we have reviewed Item 4.01, Changes in Registrant’s Certifying Accountant, of the Company’s Form 8-K dated March 10, 2014 and are in agreement with the statements made therein as it pertains to our firm.
Yours truly,
/s/ SATURNA GROUP CHARTERED ACCOUNTANTS LLP
Saturna Group Chartered Accountants LLP
Vancouver, Canada
March 18, 2014
1